These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8721436)

  • 1. Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine.
    Buemi M; Denuzzo G; Allegra A; Aloisi C; Squadrito F; Squadrito G; Dattola A; Corica F; Vermiglio G
    Int J Microcirc Clin Exp; 1995; 15(6):283-6. PubMed ID: 8721436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
    Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L
    Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin impairs endothelium-dependent vasorelaxation through cyclooxygenase-dependent mechanisms in humans.
    Wada Y; Matsuoka H; Tamai O; Kohno K; Okuda S; Imaizumi T
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):980-7. PubMed ID: 10560784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of radiographic contrast media on endothelium derived nitric oxide-dependent renal vasodilatation.
    Morcos SK; Oldroyd S; Haylor J
    Br J Radiol; 1997 Feb; 70():154-9. PubMed ID: 9135441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin ameliorated endothelial dysfunction and macrophage infiltration by increasing nitric oxide in hypertensive 5/6 nephrectomized rat aorta.
    Toba H; Morishita M; Tojo C; Nakano A; Oshima Y; Kojima Y; Yoshida M; Nakashima K; Wang J; Kobara M; Nakata T
    Eur J Pharmacol; 2011 Apr; 656(1-3):81-7. PubMed ID: 21296066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
    Panza JA; Casino PR; Badar DM; Quyyumi AA
    Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: role of reactive oxygen species.
    Karasu C
    Eur J Pharmacol; 2000 Mar; 392(3):163-73. PubMed ID: 10762670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lipoprotein(a) impair endothelial function?
    Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
    J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the β-common receptor by erythropoietin impairs acetylcholine-mediated vasodilation in mouse mesenteric arterioles.
    Kilar CR; Diao Y; Sautina L; Sekharan S; Keinan S; Carpino B; Conrad KP; Mohandas R; Segal MS
    Physiol Rep; 2018 Jun; 6(12):e13751. PubMed ID: 29939494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
    Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
    Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers: randomized evaluation of rofecoxib versus naproxen on endothelium-dependent vasodilatation.
    Verma S; Raj SR; Shewchuk L; Mather KJ; Anderson TJ
    Circulation; 2001 Dec; 104(24):2879-82. PubMed ID: 11739299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
    Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
    Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide.
    Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P
    J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of glibenclamide on acetylcholine and sodium nitroprusside induced vasodilatation in human cutaneous microcirculation.
    Hojs N; Strucl M; Cankar K
    Clin Physiol Funct Imaging; 2009 Jan; 29(1):38-44. PubMed ID: 18823336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
    Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
    J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vasodilation to acetylcholine in patients with essential hypertension.
    Rossi M; Taddei S; Fabbri A; Tintori G; Credidio L; Virdis A; Ghiadoni L; Salvetti A; Giusti C
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):406-11. PubMed ID: 9125680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients.
    Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
    J Am Coll Cardiol; 1994 Mar; 23(4):844-50. PubMed ID: 8106688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-dependent vasodilatory signalling modulates α
    Hearon CM; Kirby BS; Luckasen GJ; Larson DG; Dinenno FA
    J Physiol; 2016 Dec; 594(24):7435-7453. PubMed ID: 27561916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients.
    Taddei S; Virdis A; Ghiadoni L; Mattei P; Salvetti A
    J Hypertens; 1998 Apr; 16(4):447-56. PubMed ID: 9797190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids.
    Bode-Böger SM; Böger RH; Kuhn M; Radermacher J; Frölich JC
    Kidney Int; 1996 Oct; 50(4):1255-61. PubMed ID: 8887285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.